0.0700
+0.0050
+(7.69%)
As of 12:52:41 PM EST. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2022) | Next Qtr. (Mar 2023) | Current Year (2022) | Next Year (2023) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | 0.31 | 0.08 | -1.6 | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2022) | Next Qtr. (Mar 2023) | Current Year (2022) | Next Year (2023) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| Currency in USD | 12/31/2021 | 3/31/2022 | 6/30/2022 | 9/30/2022 |
|---|---|---|---|---|
| EPS Est. | 0.19 | 0.13 | 0.06 | 0.02 |
| EPS Actual | 0.31 | 0.08 | -0.14 | -0.27 |
| Difference | 0.12 | -0.04 | -0.21 | -0.29 |
| Surprise % | 60.69% | -35.43% | -324.31% | -1,684.50% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2022) | Next Qtr. (Mar 2023) | Current Year (2022) | Next Year (2023) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2022) | Next Qtr. (Mar 2023) | Current Year (2022) | Next Year (2023) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | 1 | 2 | 2 | 3 |
| Down Last 30 Days | 1 | 2 | 2 | 3 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| FXLV | -- | -- | -- | -- |
| S&P 500 | 8.58% | 11.41% | 13.97% | 13.43% |
Upgrades & Downgrades
| Maintains | Baird: Neutral | 3/20/2023 |
| Maintains | Goldman Sachs: Neutral | 11/16/2022 |
| Downgrade | JP Morgan: Overweight to Neutral | 10/4/2022 |
| Downgrade | Guggenheim: Buy to Neutral | 7/28/2022 |
| Downgrade | Baird: Outperform to Neutral | 7/27/2022 |
| Downgrade | Macquarie: Outperform to Neutral | 7/27/2022 |